Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.76 USD | +1.16% | +3.89% | +52.71% |
May. 28 | Nurix Therapeutics, Inc. Appoints Paula G. O?Connor as Chief Medical Officer and Pasit Phiasivongsa as Chief Technical Officer | CI |
May. 20 | Nurix Therapeutics Names New Board Chair | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+52.71% | 924M | |
+11.91% | 114B | |
+11.60% | 105B | |
-4.68% | 23.83B | |
-0.82% | 21.73B | |
-10.12% | 18.1B | |
-42.12% | 16.34B | |
-17.47% | 16.13B | |
+2.77% | 13.75B | |
+34.58% | 11.76B |
- Stock Market
- Equities
- NRIX Stock
- News Nurix Therapeutics, Inc.
- Oppenheimer Initiates Coverage on Nurix Therapeutics With Outperform Rating, $25 Price Target